Hepatitis B Virus Infection in HIV-Positive Individuals in the UK Collaborative HIV Cohort (UK CHIC) Study

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Price, Huw ^a   Bansi, Loveleen ^a   Sabin, Caroline A ^a   Bhagani, Sanjay ^b   Burroughs, Andrew ^b   Chadwick, David ^c   Dunn, David ^d   Fisher, Martin ^e   Main, Janice ^f   Nelson, Mark ^g   Pillay, Deenan ^a   Rodger, Alison ^a   Taylor, Chris ^h   Gilson, Richard ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^h KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE; ARTICLE; CAUCASIAN; COHORT ANALYSIS; ETHNIC GROUP; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MIXED INFECTION; NEGRO; OBSERVATIONAL STUDY; PREVALENCE; SEROCONVERSION; SEXUAL TRANSMISSION; UNITED KINGDOM; VACCINATION; COINFECTION; COMPLICATION; STATISTICS AND NUMERICAL DATA;

HEPATITIS B VIRUS;

COHORT STUDIES; COINFECTION; FEMALE; GREAT BRITAIN; HEPATITIS B; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; PREVALENCE; VACCINATION;

EID: 84868696427     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049314     Document Type: Article

References (20)

1. WHO (1996) The world health report 1996- Fighting disease, fostering development. Geneva: World Health Organization.
2. UNAIDS (2010) Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva, Switzerland: UNAIDS.
3. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, et al. (1997) Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 11: 597-606.
4. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, et al. (2005) Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 19: 593-601.
5. Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, et al. (2009) Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis 48: 1763-1771.
6. Hoffmann CJ, Seaberg EC, Young S, Witt MD, D'Acunto K, et al. (2009) Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS 23: 1881-1889.
7. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD, (2000) Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 283: 74-80.
8. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, et al. (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360: 1921-1926.
9. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, et al. (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 352: 1725-1730.
10. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, et al. (2006) Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 166: 1632-1641.
11. Health Protection Agency (2009) Surveillance of markers of infection detected in antenatal samples tested by NHS Blood and Transplant (NHSBT): England, 2008. Health Protection Report 3(12): 16-21.
12. Brook G, Main J, Nelson M, Bhagani S, Wilkins E, et al. (2010) British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010. HIV Med 11: 1-30.
13. Steedman NM, McMillan A, (2008) Hepatitis B testing and vaccination in patients recently diagnosed with HIV infection. Int J STD AIDS 19: 83-84.
14. Hakeem L, Thomson G, McCleary E, Bhattacharyya D, Banerjee I, (2010) Prevalence and Immunization Status of Hepatitis B Virus in the HIV Cohort in Fife, Scotland. J Clin Med Res 2: 34-38.
15. Health Protection Agency (2010) HIV in the United Kingdom: 2010 Report. Health Protection Report 4: 6-14.
16. Shulman NR, Barker LF, (1969) Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science 165: 304-306.
17. Psevdos G Jr, Kim JH, Suh JS, Sharp VL, (2010) Predictors of loss of hepatitis B surface antigen in HIV-infected patients. World J Gastroenterol 16: 1093-1096.
18. Hadler SC, Judson FN, O'Malley PM, Altman NL, Penley K, et al. (1991) Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 163: 454-459.
19. Bodsworth NJ, Cooper DA, Donovan B, (1991) The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis 163: 1138-1140.
20. Health Protection Agency (2012) United Kingdom New HIV diagnoses to end of December 2011. Black Africans and black Caribbeans.